No abstract available
MeSH terms
-
Adenoviridae Infections / drug therapy
-
Adenoviridae Infections / epidemiology
-
Antifungal Agents / therapeutic use
-
Antiviral Agents / therapeutic use
-
Bone Marrow Transplantation* / adverse effects
-
Cytomegalovirus / physiology
-
Cytomegalovirus Infections / drug therapy
-
Cytomegalovirus Infections / epidemiology
-
Cytomegalovirus Infections / transmission
-
Epstein-Barr Virus Infections / drug therapy
-
Epstein-Barr Virus Infections / epidemiology
-
Epstein-Barr Virus Infections / transmission
-
Herpesvirus 4, Human / physiology
-
Humans
-
Immunocompromised Host
-
Immunosuppression Therapy / adverse effects
-
Infections / epidemiology*
-
Infections / etiology
-
Infections / transmission
-
Mycoses / drug therapy
-
Mycoses / epidemiology
-
Mycoses / etiology
-
Postoperative Complications / drug therapy
-
Postoperative Complications / epidemiology*
-
Postoperative Complications / microbiology
-
Postoperative Complications / virology
-
Postoperative Period
-
Risk Factors
-
Transplantation Conditioning / adverse effects
-
Transplantation, Autologous
-
Transplantation, Homologous / adverse effects
-
Virus Activation
Substances
-
Antifungal Agents
-
Antiviral Agents